OCUGEN, INC. (OCGN) Debt Components
- 2026-06-30: Long-term Debt, Current MaturitiesUSD $20.00K; Long-term Debt, Excluding Current MaturitiesUSD $1.73M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $5.00M; Long-term Debt, Excluding Current MaturitiesUSD $24.19M; Long-Term Debt, Maturity, Year OneUSD $16.00M; Long-Term Debt, Maturity, Year TwoUSD $13.75M.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $1.25M; Long-term Debt, Excluding Current MaturitiesUSD $27.54M; Long-Term Debt, Maturity, Year OneUSD (m); Long-Term Debt, Maturity, Year TwoUSD (m).
- 2025-12-31: Long-term Debt, Current MaturitiesUSD (m); Long-term Debt, Excluding Current MaturitiesUSD (m); Long-Term Debt, Maturity, Year OneUSD $1.25M; Long-Term Debt, Maturity, Year TwoUSD $16.00M.
OCUGEN, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Year Four USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Long-term Debt, Gross USD | Debt Instrument, Fair Value Disclosure USD | Short-term Debt USD | Long-term Debt USD | Long-Term Debt, Maturity, Year Five USD | Long-Term Debt, Maturity, after Year Five USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $20.00K | $1.73M | (m) | (m) | (m) | (m) | (m) | (m) | $1.75M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $5.00M | $24.19M | $16.00M | $13.75M | $500.00K | (m) | $1.25M | $31.50M | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.25M | $27.54M | (m) | (m) | (m) | (m) | (m) | (m) | $28.79M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | (m) | $1.25M | $16.00M | $13.75M | (m) | (m) | $31.50M | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $28.40M | $1.25M | $16.00M | $13.75M | (m) | $0.00 | $31.50M | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $28.02M | $1.25M | $16.00M | $13.75M | (m) | $0.00 | $31.50M | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $27.67M | $1.25M | $16.00M | $13.75M | (m) | $0.00 | $31.50M | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.33M | $27.34M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | (m) | $1.00M | $1.25M | $16.00M | $13.75M | (m) | $32.50M | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $1.32M | $1.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $1.31M | $1.55M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $1.30M | $1.53M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $2.80M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $1.28M | $1.50M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $1.27M | $1.47M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $1.26M | $1.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $2.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $2.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $1.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $1.73M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $1.71M | (m) | (m) |
| 2021-09-30 | (m) | $1.69M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $1.69M | (m) | (m) |
| 2021-06-30 | (m) | $1.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $1.67M | (m) | (m) |
| 2021-03-31 | (m) | $1.70M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $374.00K | $2.08M | (m) | (m) |
| 2020-12-31 | (m) | $1.82M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $234.00K | $2.06M | (m) | (m) |
| 2020-12-31 | (m) | (m) | $234.12K | $187.30K | $0.00 | $0.00 | (m) | $1.92M | (m) | (m) | (m) | $0.00 | $1.50M |
| 2020-09-30 | (m) | $1.94M | $327.77K | $0.00 | $0.00 | $0.00 | $1.36M | $3.18M | (m) | $1.21M | $3.16M | (m) | (m) |
| 2020-06-30 | (m) | $2.02M | $421.42K | $0.00 | $0.00 | $0.00 | $4.49M | $6.41M | (m) | $4.07M | $6.09M | (m) | (m) |
| 2020-03-31 | (m) | $1.58M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | $1.07M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | $1.07M | (m) | (m) |
| 2019-09-30 | (m) | $1.06M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $2.06M | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.02M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $7.48M | (m) | (m) | (m) |
| 2017-09-30 | (m) | (m) | (m) | $178.00K | (m) | (m) | $146.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | $178.00K | (m) | (m) | $292.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | $178.00K | (m) | (m) | $438.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | (m) | (m) | (m) | $583.00K | $178.00K | (m) | $146.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | (m) | (m) | (m) | $583.00K | $178.00K | (m) | $292.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | (m) | (m) | (m) | $583.00K | $178.00K | (m) | $437.00K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | (m) | (m) | (m) | $583.00K | $178.00K | (m) | $583.00K | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B |